Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits
Document Format Files
Seq | Description | Document | Type | Size |
1 | CURRENT REPORT | form8k.htmiXBRL | 8-K | 42167 |
2 | ex10-1.htm | EX-10.1 | 818648 | |
Complete submission text file | 0000950157-19-000879.txt | 1158293 |
Data Files
Seq | Description | Document | Type | Size |
3 | XBRL TAXONOMY EXTENSION SCHEMA | akrx-20190809.xsd | EX-101.SCH | 4377 |
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | akrx-20190809_lab.xml | EX-101.LAB | 23692 |
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | akrx-20190809_pre.xml | EX-101.PRE | 16824 |
6 | EXTRACTED XBRL INSTANCE DOCUMENT | form8k_htm.xml | XML | 4058 |
IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32360 | Film No.: 191014329
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1
Attachments
- Original document
- Permalink
Disclaimer
Akorn Inc. published this content on 12 August 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 August 2019 10:35:07 UTC